Greenleaf Trust Biogen Inc. Transaction History

Greenleaf Trust

$10.7 Billion
Q1 2024

A detailed history of Greenleaf Trust transactions in Biogen Inc. stock. As of the latest transaction made, Greenleaf Trust holds 1,471 shares of BIIB stock, worth $330,401. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,471

Previous 2,155 31.74%

Holding current value

$330,401

Previous $557,000 43.09%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$212.02 - $267.71 $145,021 - $183,113	-684 Reduced 31.74%	1,471 $317,000
Q4 2023 Jan 31, 2024	BUY	$222.59 - $267.94 $81,245 - $97,798	365 Added 20.39%	2,155 $557,000
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $43,314 - $48,887	171 Added 10.56%	1,790 $460,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $5,229 - $6,043	19 Added 1.19%	1,619 $461,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $62,600 - $71,330	-244 Reduced 13.23%	1,600 $444,000

Q4 2022 Jan 25, 2023	BUY	$252.44 - $306.72 $181,504 - $220,531	719 Added 63.91%	1,844 $511,000
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $194 - $268	-1 Reduced 0.09%	1,125 $300,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $112,899 - $134,258	-602 Reduced 34.84%	1,126 $230,000
Q1 2022 Apr 27, 2022	SELL	$193.77 - $244.14 $30,809 - $38,818	-159 Reduced 8.43%	1,728 $364,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $339,014 - $435,683	-1,514 Reduced 44.52%	1,887 $453,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $367,321 - $479,026	1,298 Added 61.72%	3,401 $962,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $47,138 - $75,477	-182 Reduced 7.96%	2,103 $728,000
Q1 2021 Apr 30, 2021	BUY	$242.95 - $284.63 $129,249 - $151,423	532 Added 30.35%	2,285 $639,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $123,327 - $185,638	-522 Reduced 22.95%	1,753 $429,000
Q3 2020 Oct 30, 2020	BUY	$264.77 - $305.71 $96,376 - $111,278	364 Added 19.05%	2,275 $645,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $56,129 - $74,333	-217 Reduced 10.2%	1,911 $511,000
Q1 2020 Apr 29, 2020	BUY	$268.85 - $341.04 $138,995 - $176,317	517 Added 32.09%	2,128 $673,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $4,841 - $6,689	22 Added 1.38%	1,611 $478,000
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $156,774 - $175,837	-721 Reduced 31.21%	1,589 $370,000
Q2 2019 Jul 24, 2019	BUY	$219.29 - $241.72 $89,031 - $98,138	406 Added 21.32%	2,310 $540,000
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $141,945 - $222,018	-655 Reduced 25.6%	1,904 $450,000
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $32,027 - $40,566	115 Added 4.71%	2,559 $770,000
Q3 2018 Oct 29, 2018	BUY	$293.51 - $383.83 $287,639 - $376,153	980 Added 66.94%	2,444 $863,000
Q2 2018 Aug 07, 2018	BUY	$257.52 - $306.91 $164,040 - $195,501	637 Added 77.03%	1,464 $425,000
Q1 2018 Apr 30, 2018	SELL	$260.13 - $367.91 $20,810 - $29,432	-80 Reduced 8.82%	827 $226,000
Q4 2017 Feb 08, 2018	BUY	$307.64 - $344.58 $23,380 - $26,188	76 Added 9.15%	907 $289,000
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $233,635 - $273,972	831	831 $260,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account